Thomas McFarlane (Tom McFarlane)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Venues

Medical decision making : an international journal of the Society for Medical Decision Making

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Future oncology (London, England)

International journal of clinical pharmacy

University of Waterloo Faculty of Science

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Waterloo Faculty of Science Jan 01 2010

Canada

Adjunct Clinical Assistant Professor/Clinical Lecturer :: Pharmacy

Publications

Lisa Masucci, Feng Tian, Stephen Tully, Zeny Feng, Thomas McFarlane, Kelvin Kar-Wing Chan, William W L Wong
CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis. Medical decision making : an international journal of the Society for Medical Decision Making 44 (3) (2024)
Lisa Masucci, Feng Tian, Stephen Tully, Zeny Feng, Thomas McFarlane, Kelvin Kar-Wing Chan, William W L Wong
CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis. Medical decision making : an international journal of the Society for Medical Decision Making 44 (3) (2024)
Andrew Ruplin, Eve Segal, Thomas McFarlane
Review of drug-drug interactions in patients with prostate cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Andrew Ruplin, Eve Segal, Thomas McFarlane
Review of drug-drug interactions in patients with prostate cancer. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Lisa Masucci, Feng Tian, Stephen Tully, Zeny Feng, Thomas McFarlane, Kelvin Kar-Wing Chan, William W L Wong
CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis. Medical decision making : an international journal of the Society for Medical Decision Making 44 (3) (2024)
Lisa Masucci, Feng Tian, Stephen Tully, Zeny Feng, Thomas McFarlane, Kelvin Kar-Wing Chan, William W L Wong
CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis. Medical decision making : an international journal of the Society for Medical Decision Making (2024)
Lisa Masucci, Feng Tian, Stephen Tully, Zeny Feng, Thomas McFarlane, Kelvin Kar-Wing Chan, William W L Wong
CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis. Medical decision making : an international journal of the Society for Medical Decision Making 44 (3) (2024)
Lisa Masucci, Feng Tian, Stephen Tully, Zeny Feng, Thomas McFarlane, Kelvin Kar-Wing Chan, William W L Wong
CAR T-cell Therapy for Diffuse Large B-cell Lymphoma in Canada: A Cost-Utility Analysis. Medical decision making : an international journal of the Society for Medical Decision Making 44 (3) (2024)
Jan-Willem Henning, Jean-François Boileau, Larissa Peck, Thomas McFarlane
Clinical Considerations for the Integration of Adjuvant Olaparib into Practice for Early Breast Cancer: A Canadian Perspective. Current oncology (Toronto, Ont.) 30 (8) (2023)
Alisha Merali, Maria Anwar, Jamie M Boyd, Thomas McFarlane, Melanie Daniluk
Exploration of current pharmacy practice in cardio-oncology: Experiences & perspectives. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Yong-Jin Kim, Mark Oremus, Helen H Chen, Thomas McFarlane, Danielle Fearon, Susan Horton
Factors affecting treatment selection and overall survival for first-line EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer. Journal of comparative effectiveness research 10 (3) (2021)
Yong-Jin Kim, Mark Oremus, Helen H Chen, Thomas McFarlane, Danielle Fearon, Susan Horton
Cost-Effectiveness Analysis of Afatinib, Erlotinib, and Gefitinib as First-Line Treatments for EGFR Mutation-Positive Non-Small-Cell Lung Cancer in Ontario, Canada. PharmacoEconomics 39 (5) (2021)
Yong-Jin Kim, Mark Oremus, Helen H Chen, Thomas McFarlane, Devanshi Shah, Susan Horton
Real-world effectiveness of nivolumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis. Future oncology (London, England) 16 (27) (2020)
Tejal Patel, Sumaira Hasan, Feng Chang, Thomas McFarlane
Controlled substances in hospices after patient death: a cross-sectional survey of Ontario hospices. International journal of clinical pharmacy 42 (5) (2020)

Thomas McFarlane.css-eqlu8i{font-size:small;padding-left:4px;} (Tom McFarlane)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas McFarlane (Tom McFarlane)